Table 6 |
|||
|
Patient characteristics by albumin status for the propensity matched patients |
|||
|
Albumin (n = 339) |
No albumin (n = 339) |
p value |
|
|
|
|||
|
Age, mean ± SD |
62.6 ± 15.1 |
62.6 ± 17.1 |
0.365 |
|
Male gender (%) |
221 (62.2) |
206 (60.8) |
0.693 |
|
Chronic diseases (%) |
|||
|
COPD |
37 (10.9) |
33 (9.7) |
0.614 |
|
Cancer |
61 (18.0) |
62 (18.3) |
0.921 |
|
Heart failure |
40 (11.8) |
43 (12.7) |
0.725 |
|
Diabetes |
27 (8.0) |
34 (10.0) |
0.347 |
|
Liver cirrhosis |
30 (8.8) |
26 (7.7) |
0.577 |
|
Hematologic cancer |
12 (3.5) |
10 (2.9) |
0.665 |
|
HIV/AIDS |
5 (1.5) |
7 (2.1) |
1.000 |
|
Surgical admissions (%) |
208 (61.4) |
215 (63.4) |
0.579 |
|
SAPS II score, mean ± SD |
41.7 ± 17.2 |
41.6 ± 18.1 |
0.664 |
|
SOFA score, mean ± SDa |
7.1 ± 4.1 |
6.7 ± 4.4 |
0.126 |
|
Organ failurea |
|||
|
Respiratory |
106 (31.3) |
100 (29.5) |
0.616 |
|
Hepatic |
16 (4.7) |
15 (4.4) |
0.854 |
|
Coagulation |
39 (11.5) |
27 (8.0) |
0.120 |
|
Renal |
72 (21.2) |
71 (20.9) |
0.925 |
|
CNS |
70 (20.6) |
79 (23.3) |
0.404 |
|
Cardiovascular |
147 (43.4) |
146 (43.1) |
0.939 |
|
Sepsis syndromes (%)a |
|||
|
Sepsis |
120 (35.4) |
132 (38.9) |
0.441 |
|
Severe sepsis |
103 (30.4) |
101 (29.8) |
0.867 |
|
Septic shock |
57 (16.8) |
50 (14.7) |
0.461 |
|
Procedures (%)a |
|||
|
Mechanical ventilation |
259 (76.4) |
255 (75.5) |
0.720 |
|
Pulmonary artery catheter |
71 (20.9) |
58 (17.1) |
0.203 |
|
Hemofiltration |
23 (6.8) |
17 (5.0) |
0.335 |
|
Hemodialysis |
11 (3.2) |
9 (2.7) |
0.650 |
|
Mean fluid balance ± SD |
0.2 ± 1.3 |
0.2 ± 1.4 |
0.474 |
|
Trauma |
18 (5.3) |
14 (4.1) |
0.446 |
|
ICU mortality (%) |
118 (34.8) |
71 (20.9) |
<0.001 |
|
Hospital mortality (%) |
140 (41.3) |
94 (27.7) |
<0.001 |
|
|
|||
|
aOn the day of albumin administration in the albumin group and on admission in the others. CNS, central nervous system; ICU, intensive care unit; IQ, interquartile range; SAPS, simplified acute physiology score; SD, standard deviation; SOFA, sequential organ failure assessment; COPD: chronic obstructive pulmonary disease. |
|||
|
Vincent et al. Critical Care 2005 9:R745 doi:10.1186/cc3895 |
|||
